US HB7630 | 2021-2022 | 117th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 76-34)
Status: Introduced on April 28 2022 - 25% progression, died in committee
Action: 2022-04-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 28 2022 - 25% progression, died in committee
Action: 2022-04-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To maximize discovery, and accelerate development and availability, of promising childhood cancer treatments, and for other purposes.
Title
Childhood Cancer STAR Reauthorization Act of 2022 Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2022-04-29 | House | Referred to the Subcommittee on Health. |
| 2022-04-28 | House | Referred to the House Committee on Energy and Commerce. |
| 2022-04-28 | House | Introduced in House |
Same As/Similar To
SB4120 (Same As) 2023-01-05 - Became Public Law No: 117-350.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/7630/all-info |
| Text | https://www.congress.gov/117/bills/hr7630/BILLS-117hr7630ih.pdf |
